CASI Competitors & Alternatives

Compare CASI Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

CASI

Main Stock
$0.21
-74.06%
Tradestie Score
42
Market Cap
$26.18M
Revenue Growth
-60.5%
Analyst Upside
+1827.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Monoclonal antibodies, Small molecule oncology drugs
Major Customers 3
Hospitals Oncology clinics Specialty distributors (China/US)
Critical Suppliers 2
Contract manufacturing organizations API suppliers
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
CLSD Clearside Biomedical, Inc. Common Stock
$0.41
-26.96%
$21.88M - 42 Compare
APTO APTO
- - - - Compare
OPGN OPGN
- - - - Compare
ENG ENG
- - - - Compare
MEIP MEIP
- - - 49 Compare
BGNE BGNE
- - - - Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry